Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Telix-Pharmaceuticals

More Like This

PR Newswire associated0

Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics

PR Newswire associated0

Telix Announces Reorganisation to Deliver on Strategic Priorities

PR Newswire associated0

Telix Featured in 13 Abstracts at the Annual Congress of the European Association of Nuclear Medicine (EANM)

PR Newswire associated0

Telix and Wiik Pharma Sign Distribution Agreement for Illuccix® in the Nordic Region

PR Newswire associated0

Telix 2023 Full Year Results: Inaugural Profit Achieved, Strong Revenue Growth Underpins Investment in Late-stage Pipeline

PR Newswire associated0

Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform

PR Newswire associated0

Telix to Acquire RLS to Expand North American Manufacturing and Distribution Platform

PR Newswire associated0

Telix Submits Biologics License Application (BLA) for TLX250-CDx (Zircaix™) for Imaging of Kidney Cancer